Predictors of selenium biomarker kinetics in 4-9-year-old Bangladeshi children

Helena Skröder1, Maria Kippler1, Jessica De Loma1

  • 1Unit of Metals and Health, Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE-171 77 Stockholm, Sweden.

Environment International
|October 21, 2018
PubMed

Insights

Selenium biomarker concentrations vary due to malnutrition, genetics, and metal exposure. These factors may impact the assessment of selenium status, particularly when relying on plasma or serum levels.

Area of Science:

  • Environmental Health
  • Nutritional Science
  • Biomarker Research

Background:

  • Selenium biomarker concentrations exhibit significant inter-study variability.
  • Discrepancies in erythrocyte, urine, and hair selenium levels, even with similar plasma concentrations, indicate unknown distribution factors.

Purpose of the Study:

  • To identify predictors of varying selenium biomarker levels in children.
  • To investigate the influence of environmental and genetic factors on selenium distribution across different body compartments.

Main Methods:

  • Utilized a mother-child cohort from a supplementation trial in Bangladesh (MINIMat).
  • Measured selenium, arsenic, and cadmium in plasma, erythrocytes, urine, and hair using inductively coupled plasma mass spectrometry.
  • Genotyped for the INMT gene, involved in selenium metabolism.

Main Results:

  • Plasma selenium levels varied by season and were inversely associated with plasma arsenic.
  • Erythrocyte selenium correlated positively with erythrocyte arsenic and inversely with erythrocyte cadmium.
  • Selenium in hair and urine were influenced by INMT polymorphisms, while malnutrition appeared to increase selenium retention.

Conclusions:

  • Selenium biomarker levels are influenced by malnutrition, genetic factors (INMT), and exposure to metal pro-oxidants (arsenic, cadmium).
  • These influencing factors may complicate the accurate assessment of selenium deficiency or sufficiency, typically evaluated using plasma/serum selenium concentrations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182